2B4 (CD244) is expressed and functional on human eosinophils

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 110-118

  Munitz, Ariel ^a   Bachelet, Ido ^a   Fraenkel, Shira ^a   Katz, Gil ^a   Mandelboim, Ofer ^a   Simon, Hans Uwe ^b   Moretta, Lorenzo ^c,d   Colonna, Marco ^e   Levi Schaffer, Francesca ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF BERN   (Switzerland)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD244 ANTIGEN; CD48 ANTIGEN; CD84 ANTIGEN; EOSINOPHIL PEROXIDASE; GAMMA INTERFERON; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MITOGEN ACTIVATED PROTEIN KINASE; PERVANADATE; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BASOPHIL; CELL ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME PHOSPHORYLATION; EOSINOPHIL; HUMAN; HUMAN CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 10844284607     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.110     Document Type: Article

References (55)

1. Rothenberg, M. E., A. Mishra, E. B. Brandt, and S. P. Hogan. 2001. Gastrointestinal eosinophils. Immunol. Rev. 179:139.
2. Klion, A. D., and T. B. Nutman. 2004. The role of eosinophils in host defense against helminth parasites. J. Allergy Clin. Immunol. 113:30.
3. Weller, P. F. 1991. The immunobiology of eosinophils. N. Engl. J. Med. 324:1110.
4. Gleich, G. J. 2000. Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol. 105:651.
5. Munitz, A., and F. Levi-Schaffer. 2004. Eosinophils: new roles for old cells. Allergy 59:268.
6. Giembycz, M. A., and M. A. Lindsay. 1999. The pharmacology of the eosinophil. Pharmacol. Rev. 51:213.
7. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell mediated cytolysis. Annu. Rev. Immunol. 19:197.
8. Bochner, B. S. 2004. Verdict in the case of therapies versus eosinophils: the jury is still out. J. Allergy Clin. Immunol 113:3.
9. Tedla, N., C. Banderia-Melo, P. Tassinari, D. E. Sloane, M. Samplaski, D. Cosman, L. Borges, P. F. Weller, and J. P. Arm. 2003. Activtion of human eosinophils through leukocyte immunoglobulin-like receptor 7. Proc. Natl. Acad. Sci. USA 100:1174.
10. Nutku, E., H. Aizawa, S. A. Hudson, and B. S. Bochner. 2003. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 101:5014.
11. Munday, J., S. Kerr, J. Ni, A. L. Cornish, J. Q. Zhang, G. Nicoll, H., Floyd, M. G. Mattei, P. Moore, D. Liu, et al. 2001. Identification characterization and leukocyte expression of Siglec-10, a novel human sialic acid-binding receptor. Biochem. J. 355:489.
12. Woerly, G., N. Roger, S. Loiseau, D. Dombrowicz, A. Capron, and M. Capron. 1999. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type lcytokines (interleukin 2 and interferon γ): inhibition by immunoglobulin A complexes. J. Exp. Med. 190:487.
13. Boles, K. S., S. E. Stepp, M. Bennett, V. Kumar, and P. A. Mathew. 2001. 2B4(CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol. Rev. 181:234.
14. Sidorenko, S. P., and E. A. Clark. 2003. The dual-function CD150 receptor subfamily: the viral attraction. Nat. Immunol. 4:19.
15. Nakajima, H., M. Cella, H. Langen, A. Friedlein, and M. Colonna. 1999. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur. J. Immunol. 29:1676.
16. Brown, M. H., K. Boles, P. A. van der Merwe, V. Kumar, P. A. Mathew, and A. N. Barclay. 1998. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188:2083.
17. Chuang, S. S., P. R. Kumaresan, and P. A. Mathew. 2001. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-γ release in human NK cells involves distinct pathways. J. Immunol. 167:6210.
18. Bouchon, A., M. Cella, H. L. Grierson, J. I. Cohen, and M. Colonna. 2001. Cutting edge: activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J. Immunol. 1167:5517.
19. Tangye, S. G., S. Lazetic, E. Woollatt, G. R. Sutherland, L. L. Lanier, and J. H. Phillips. 1999. Cutting edge: human 2B4 an activating NK cell receptor recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 167:6981.
20. Nakajima, H., M. Cella, A. Bouchon, H. L. Grierson, J. Lewis, C. S. Duckett, J. I. Cohen, and M. Colonna. 2000. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30:3309.
21. Engel, P., M. J. Eck, and C. Terhorst. 2003. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat. Rev. Immunol. 3:813.
22. Morra, M., D. Howie, M. S. Grande, J. Sayos, N. Wang, C. Wu, P. Engel, and C. Terhorst. 2001. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu. Rev. Immunol. 19:657.
23. Sivori, S., M. Falco, E. Marcenaro, S. Parolini, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2002. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer precursors undergoing in vitro differentiation. Proc. Natl. Acad. Sci. USA 99:4526.
24. Bottino, C., M. Falco, S. Parolini, E. Marcenaro, R. Augugliaro, S. Sivori, E. Landi, R. Biassoni, L. D. Notarangelo, L. Moretta, et al. 2001. NTB-A a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194:235.
25. Hartman, M., A. M. Piliponsky, V. Temkin, and F. Levi-Schaffer. 2001. Human peripheral blood eosinophils express stem cell factor. Blood 97:1086.
26. Solomon, A., R. Smilowich, D. Shasha, J. Frucht-Pery, J. Pe'er, S. Bonini, and F. Levi-Schaffer. 2000. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro. Invest Ophthalmol. Visual Sci. 41:1038.
27. Mandelboim, O., H. T. Reyburn, M. Vales-Gomez, L. Pazmany, M. Colonna, G. Borsellino, and J. L. Strominger. 1996. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 184:913.
28. Yin, L., V. Ferrand, M. F. Lavoue, D. Hayoz, N. Philippe, G. Souillet, M. Seri, R. Giacchino, E. Castagnola, S. Hodgson, et al. 1999. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients. Hum. Genet. 105:501.
29. Temkin, V., B. Kantor, V. Weg, M. L. Hartman, and F. Levi-Schaffer. 2002. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J. Immunol. 169:2662.
30. Adachi, T., and R. Alam. 1998. The mechanism of IL-5 signal transduction. Am. J. Physiol. 275:623.
31. Yosefi, S., K. Blaser, and H. U. Simon. 1997. Activation of signaling pathways and prevention of apoptosis by cytokines in eosinophils. Int. Arch. Allergy Immunol. 112:9.
32. Davis, S. J., and P. A. van der Merwe. 1996. The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today 17:177.
33. Latchman, Y., P. F. McKay, and H. Reiser. 1998. Identification of the 2B4 molecule as a counter-receptor for CD48. J. Immunol. 161:5809.
34. Martin, M., X. Romero, M. A. de la Fuente, V. Tovar, N. Zapater, E. Esplugues, P. Pizcueta, J. Bosch, and P. Engel. 2001. CD84 functions as a homophilic adhesion molecule and enhances IFN-γ secretion: adhesion is mediated by Ig-like domain 1. J. Immunol. 167:3668.
35. Punnonen, J., B. G. Cocks, J. M. Carballido, B. Bennett, D. Peterson, G. Aversa, and J. E. de Vries. 1997. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med. 185:993.
36. Celestin, J., O. Rotschke, K. Falk, N. Ramesh, H. Jabara, J. Strominger, and R. S. Geha. 2001. IL-3 induces B7.2 (CD86) expression and costimulatory activity in human eosinophils. J. Immunol. 167:6097.
37. Shi, H. Z., A. Humbles, C. Gerard, Z. Jin, and P. F. Weller. 2000. Lymph node trafficking and antigen presentation by endobronchial eosinophils Clin. Invest. 105:945.
38. Lee, N. A., E. W. Gelfand, and J. J. Lee. 2001. Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology? J. Allergy Clin. Immunol. 107:945.
39. Shen, H. H., S. I. Ochkur, M. P. McGarry, J. R. Crosby, E. M. Hines, M. T. Borchers, H. Wang, T. L. Biechelle, K. R. O'Neill, T. L. Ansay, et al. 2003. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. Immunology 170:3296.
40. Garni-Wagner, B. A., A. Purohit, P. A. Mathew, M. Bennett, and V. Kumar. 1993. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J. Immunol. 151:60.
41. Mathew, P. A., B. A. Garni-Wagner, K. Land, A. Takashima, E. Stoneman, M. Bennett, and V. Kumar. 1993. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. Immunology 151:5328.
42. Sivori, S., S. Parolini, M. Falco, E. Marcenaro, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2000. 2B4 functions as a co-receptor in human NK cell activation. Eur. J. Immunol. 30:787.
43. Schuhmachers, G., K. Falco, P. A. Mathew, M. Bennett, V. Kumar, and A. Takashima. 1995. 2B4, a new member of the immunoglobulin gene superfamily, is expressed on murine dendritic epidermal T cells and plays a functional role in their killing of skin tumors. J. Invest. Dermatol. 105:592.
44. Samoszuk, M. 1997. Eosinophils and human cancer. Histol. Histopathol. 12:807.
45. Rivoltini, L., V. Viggiano, S. Spinazze, A. Santoro, M. P. Colombo, K. Takatsu, and G. Parmiani. 1993. In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2: role of interleukin 5. Int. J. Cancer 54:8.
46. Roberts, R. L., B. J. Ank, and E. R. Stiehm. 1991. Human eosinophils are more toxic than neutrophils in antibody-independent killing. J. Allergy Clin. Immunol. 87:1105.
47. + T cells in the antitumor immune response. J. Exp. Med. 188:2357.
48. Mattes, J., M. Hulett, W. Xie, S. Hogan, M. E. Rothenberg, P. Foster, and C. Parish. 2003. Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. J. Exp. Med. 197:387.
49. Kubo, H., D. A. Loegering, C. R. Adolphson, and G. J. Gleich. 1999. Cytotoxic properties, of eosinophil granule major basic protein for tumor cells. Int. Arch. Allergy Immunol. 118:426.
50. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Munz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:343.
51. Lee, K. M., M. E. McNerry, S. E. Stepp, P. A. Mathew, J. D. Schatzle, M. Bennet, and V. Kumar. 2004. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J. Exp. Med. 199:1245.
52. Klem, J., P. C. Verrett, V. Kumar, and J. D. Schatzle. 2002. 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function. J. Immunol. 169:55.
53. Chuang, S. S., J. K. Lee, and P. A. Mathew. 2003. Protein kinase C is involved in 2B4 (CD244)-mediated cytotoxicity and AP-1 activation in natural killer cells. Immunology 109:432.
54. Watzl, C., and E. O. Long. 2003. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med. 197:77.
55. Nagy, N., K. Mattsson, A. Maeda, A. Liu, L. Szekely, and E. Klein. 2002. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells. Immunol. Lett. 82:141.